WishBone and SpineGuard Sign National Distribution Agreement for U.S. Pediatric Orthopedic Centers


New partnership to expand access for pediatric orthopedic surgeons performing spine surgery

WARSAW, Ind. & BOULDER, Colorado & PARIS, January 06, 2022– (COMMERCIAL THREAD) – Regulatory news:

WishBone Medical, Inc., a leader in pediatric orthopedic medical devices, and SpineGuard (FR0011464452 – ALSGD), an innovative company deploying its dynamic surgical guidance detection (DSG) technology to secure and streamline bone implant placement announced today long-term partnership with, for the exclusive distribution rights of the PediGuard® intelligent spinal drilling devices to children’s hospitals across the United States.

“This strategic alignment with SpineGuard enables WishBone’s spine division to support and focus 100% on the pediatric spine community. Our goal is to provide clinical solutions to the unmet needs of surgeons related to improving patient safety and improving practice outcomes, ”said Jeff Wertz, Director Vice President of Spine, WishBone Medical . “Increasing accuracy rates when making a pilot hole in axially rotating spines during scoliosis surgery is critical to a successful outcome. Additionally, surgical teams can dramatically reduce the amount of radiation exposure to children associated with preoperative and intraoperative X-ray CT scans – x-rays taken during surgery – a significant risk factor that can be significantly reduced and minimized in AIS procedures. “

“We will implement this very promising collaboration in close cooperation to integrate it with our existing network of US agents, taking advantage of the new DSG Connect platform which adds visual display and data logging capabilities. . Despite the evolution of today’s spinal surgery solutions, the design logic inherent in GDM continues. to elevate the key elements that have kept DSG technology extremely relevant in this risk mitigation, low radiation exposure, minimal setup and a 12-year clinical history of delivering real-time accuracy that rivals all others much more expensive terms, ”says Patrick Pilcher Vice President, Sales and Marketing, North America SpineGuard.

Pierre Jérôme, CEO and Co-Founder of SpineGuard, adds: “We are delighted to partner with WishBone to bring our X-ray-free real-time guidance technology to more US surgeons and hospitals providing pediatric orthopedic care. and to help make spine surgery safer. This congruent alliance will significantly expand our trade footprint in the United States. WishBone has the passion, leadership and access to drive faster and wider adoption of our DSG technology in correcting spinal deformities, an integral historical foundation of SpineGuard. “

“Thanks to the contracts WishBone has with several group purchasing organizations, we are now networked with 242 of the 268 independent children’s hospitals performing orthopedic surgery,” said Nick Deeter, Founder, President and CEO of WishBone Medical. “This level of access will provide surgeons with the ability to immediately use the DSG and minimize radiation exposure for their patients. This technology is a perfect complement to WishBone’s sterile spine solutions as we strive to raise surgical standards for children.

The safety and efficacy of using DSG for spinal surgery has been proven by more than 85,000 surgeries worldwide and supported by 17 peer-reviewed scientific publications.* DSG probes provide haptic and tactile sensation, act as an internal GPS system inside the pedicle, and enhance the ability of residents and fellows to place spinal implants more precisely for increased patient safety.1 The literature maintains that DSG accuracy rates are equal to or better than navigation / robotic alternatives, without the inconvenience of disrupting surgical workflow and avoiding intraoperative CT scans. The combination of DSG technology with the ASTRA Spine Deformation System will provide a clinical solution to help meet the growing needs of the pediatric spine surgeon community.

* A complete list of support publications is available on the manufacturer’s website: https://www.spineguard.com/dynamic-surgical-guidance-technology
1. Williams, John and Samdani, Amer and Defino, Helton and George, Keri and Gaughan, John and Betz, Randal. (2014). Anticipation of the breach of the vertebral pedicle by dynamic surgical guidance. Coluna / Columna. 13. 210-213. 10.1590 / S1808-18512014130300R85.

About SpineGuard®

Founded in 2009 in France and the USA by Pierre Jérôme and Stéphane Bette, SpineGuard is an innovative company deploying its proprietary real-time detection technology without DSG® radiation (Dynamic Surgical Guidance) to secure and rationalize the placement of implants in the skeleton . SpineGuard designs, develops and markets medical devices that have been used in more than 85,000 surgical procedures worldwide. Seventeen studies published in peer-reviewed scientific journals have demonstrated the multiple benefits offered by DSG® to patients, surgeons, surgical staff and hospitals. On the strength of these solid fundamentals and several strategic partnerships, SpineGuard has extended its technological platform with a breakthrough innovation: the “intelligent” pedicle screw launched at the end of 2017 and broadens the field of applications in dental implantology and surgical robotics. DSG® was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, MD, Ph.D., and Alain Vanquaethem, biomedical engineer. SpineGuard is engaged in several ESG initiatives. For more information visit www.spineguard.com


SpineGuard securities may not be offered or sold in the United States because they have not been and will not be registered under the Securities Act or any securities law of the United States, and SpineGuard has not intends to make a public offering of its securities in the United States. This is an announcement and not a prospectus, and the information contained in this document does not constitute and does not constitute an offer to sell or the solicitation of an offer to buy, and there will be no nor any sale of the securities referred to herein in the United States in which such an offer, solicitation or sale would be unlawful prior to registration or exemption from registration.

About WishBone Medical

WishBone Medical is a global pediatric orthopedics company committed to providing anatomically appropriate implants and instruments in sterile, single-use intervention kits designed to prevent infections, reduce overall costs to clients, and achieve the best results. better outcomes for children around the world. The WishBone Medical family of companies offers a comprehensive product line of “head to toe” innovative systems with operations in Warsaw, IN; Istanbul and Singapore. For more information visit www.WishBoneMedical.com or contact Kaitlyn Hughes, Director of Marketing and Communications, at + 1-574-306-4006.

See the source version on businesswire.com: https://www.businesswire.com/news/home/20220106005826/en/


Pierre Jerome
CEO & President
Phone: +33 1 45 18 45 19
[email protected]

Investor Relations & Financial Communication
Mathilde Bohin / Pierre Laurent
Phone: +33 1 44 71 94 94
[email protected]

Kaitlyn hughes
Phone. : + 1-574-306-4006
[email protected]


Comments are closed.